What is CureMetrix?
CureMetrix is recognized globally as a leader in applying artificial intelligence (AI) to medical imaging. The company is dedicated to advancing technology that directly contributes to improving cancer survival rates worldwide. By utilizing deep learning and AI, CureMetrix develops next-generation medical image analysis tools, providing radiologists, healthcare systems, and patients with reliable and advanced solutions. Their commitment to 'CAD that Works®' highlights their focus on delivering practical and effective AI-driven diagnostic support.
How much funding has CureMetrix raised?
CureMetrix has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for CureMetrix?
The substantial large-scale late-stage funding positions CureMetrix for accelerated growth and market expansion. This strategic backing is expected to fuel further research and development in AI-powered medical imaging, potentially leading to broader adoption of their solutions across healthcare networks. The company is poised to solidify its leadership in the competitive MedTech landscape, driving innovation that could redefine cancer detection and diagnosis.
See full CureMetrix company page
